Interferon-alpha-2a. A review of its pharmacological properties and therapeutic use in the management of viral hepatitis

Drugs
M Haria, P Benfield

Abstract

Interferon-alpha-2a is a recombinant interferon with antiviral, antitumour and immunomodulatory properties. Clinical studies have demonstrated that the drug offers therapeutic benefit in patients with some forms of chronic viral hepatitis. Remission, as measured by clearance of viral DNA and hepatitis B 'e' antigen (HBeAg), and normalisation of serum alanine aminotransferase levels, is observed in approximately 30 to 45% of patients with chronic hepatitis B receiving interferon-alpha-2a (2.5 to 18MU administered 3 times/week); about 5 to 15% of untreated controls remit spontaneously every year. Complete recovery [with loss of hepatitis B surface antigen (HBsAg)] is usually noted in < 20% of treated individuals. Similar response rates have been reported in the relatively small number of children evaluated to date. Although numerous studies have shown that interferon-alpha-2a (at various dosages) induces biochemical amelioration of chronic hepatitis C in approximately 50 to 75% of patients, relapse is common. Thus, long term remission may only be observed in about 15 to 30% of treated patients. On the other hand, this disorder remits spontaneously in only a few patients. The role of interferon-alpha-2a in the treatment of chronic...Continue Reading

Citations

Jun 1, 1997·Journal of the American Geriatrics Society·E L Marcus, R Tur-Kaspa
Jul 26, 2005·Phytotherapy Research : PTR·Dur Han KwonYong Kyung Choi
Jul 27, 2006·Basic & Clinical Pharmacology & Toxicology·Victor E BuckwoldPeter Langecker
Feb 21, 1998·Proceedings of the National Academy of Sciences of the United States of America·J PetersenC E Rogler
Jun 1, 2002·Paediatric Drugs·Etienne Sokal
Mar 15, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J HoffF Raffi
Jan 19, 2005·World Journal of Gastroenterology : WJG·Geng-Tao LiuLing-Zhi Wang
Feb 24, 2007·International Ophthalmology·Valerie TouitouBahram Bodaghi
Nov 6, 2008·Expert Opinion on Drug Safety·Nikroo HashemiSteven K Herrine
Mar 16, 2004·Fundamental & Clinical Pharmacology·Necati Ormeci
May 3, 2002·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Mark SulkowskiJian Yu
Apr 25, 2006·European Psychiatry : the Journal of the Association of European Psychiatrists·Klaus LiebMartin Schaefer
Apr 14, 2012·Tropical Medicine and Health·Lyre Anni Espada-Murao, Kouichi Morita
Feb 21, 2021·Advanced Drug Delivery Reviews·Pyae PhyoYongchao Su
Mar 28, 2003·Journal of Pharmaceutical Sciences·Vikas K Sharma, Devendra S Kalonia
Dec 18, 2003·Clinics in Dermatology·Peggy LinStephen K Tyring

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.